BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 29334375)

  • 1. A small-molecule inhibitor of the ubiquitin activating enzyme for cancer treatment.
    Hyer ML; Milhollen MA; Ciavarri J; Fleming P; Traore T; Sappal D; Huck J; Shi J; Gavin J; Brownell J; Yang Y; Stringer B; Griffin R; Bruzzese F; Soucy T; Duffy J; Rabino C; Riceberg J; Hoar K; Lublinsky A; Menon S; Sintchak M; Bump N; Pulukuri SM; Langston S; Tirrell S; Kuranda M; Veiby P; Newcomb J; Li P; Wu JT; Powe J; Dick LR; Greenspan P; Galvin K; Manfredi M; Claiborne C; Amidon BS; Bence NF
    Nat Med; 2018 Feb; 24(2):186-193. PubMed ID: 29334375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical evaluation of the selective small-molecule UBA1 inhibitor, TAK-243, in acute myeloid leukemia.
    Barghout SH; Patel PS; Wang X; Xu GW; Kavanagh S; Halgas O; Zarabi SF; Gronda M; Hurren R; Jeyaraju DV; MacLean N; Brennan S; Hyer ML; Berger A; Traore T; Milhollen M; Smith AC; Minden MD; Pai EF; Hakem R; Schimmer AD
    Leukemia; 2019 Jan; 33(1):37-51. PubMed ID: 29884901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting ubiquitin-activating enzyme induces ER stress-mediated apoptosis in B-cell lymphoma cells.
    Best S; Hashiguchi T; Kittai A; Bruss N; Paiva C; Okada C; Liu T; Berger A; Danilov AV
    Blood Adv; 2019 Jan; 3(1):51-62. PubMed ID: 30617217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissecting the Specificity of Adenosyl Sulfamate Inhibitors Targeting the Ubiquitin-Activating Enzyme.
    Misra M; Kuhn M; Löbel M; An H; Statsyuk AV; Sotriffer C; Schindelin H
    Structure; 2017 Jul; 25(7):1120-1129.e3. PubMed ID: 28578874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small Molecule Inhibitors Confirm Ubiquitin-Dependent Removal of TOP2-DNA Covalent Complexes.
    Swan RL; Poh LLK; Cowell IG; Austin CA
    Mol Pharmacol; 2020 Sep; 98(3):222-233. PubMed ID: 32587095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lead discovery and chemical biology approaches targeting the ubiquitin proteasome system.
    Akinjiyan FA; Carbonneau S; Ross NT
    Bioorg Med Chem Lett; 2017 Oct; 27(20):4589-4596. PubMed ID: 28911816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the ubiquitin-proteasome system by an NQO1-activatable compound.
    Giovannucci TA; Salomons FA; Haraldsson M; Elfman LHM; Wickström M; Young P; Lundbäck T; Eirich J; Altun M; Jafari R; Gustavsson AL; Johnsen JI; Dantuma NP
    Cell Death Dis; 2021 Oct; 12(10):914. PubMed ID: 34615851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of TAK-981, a First-in-Class Inhibitor of SUMO-Activating Enzyme for the Treatment of Cancer.
    Langston SP; Grossman S; England D; Afroze R; Bence N; Bowman D; Bump N; Chau R; Chuang BC; Claiborne C; Cohen L; Connolly K; Duffey M; Durvasula N; Freeze S; Gallery M; Galvin K; Gaulin J; Gershman R; Greenspan P; Grieves J; Guo J; Gulavita N; Hailu S; He X; Hoar K; Hu Y; Hu Z; Ito M; Kim MS; Lane SW; Lok D; Lublinsky A; Mallender W; McIntyre C; Minissale J; Mizutani H; Mizutani M; Molchinova N; Ono K; Patil A; Qian M; Riceberg J; Shindi V; Sintchak MD; Song K; Soucy T; Wang Y; Xu H; Yang X; Zawadzka A; Zhang J; Pulukuri SM
    J Med Chem; 2021 Mar; 64(5):2501-2520. PubMed ID: 33631934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ubiquitin-activating enzyme inhibition induces an unfolded protein response and overcomes drug resistance in myeloma.
    Zhuang J; Shirazi F; Singh RK; Kuiatse I; Wang H; Lee HC; Berkova Z; Berger A; Hyer M; Chattopadhyay N; Syed S; Shi JQ; Yu J; Shinde V; Tirrell S; Jones RJ; Wang Z; Davis RE; Orlowski RZ
    Blood; 2019 Apr; 133(14):1572-1584. PubMed ID: 30737236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SLFN11 Inactivation Induces Proteotoxic Stress and Sensitizes Cancer Cells to Ubiquitin Activating Enzyme Inhibitor TAK-243.
    Murai Y; Jo U; Murai J; Jenkins LM; Huang SN; Chakka S; Chen L; Cheng K; Fukuda S; Takebe N; Pommier Y
    Cancer Res; 2021 Jun; 81(11):3067-3078. PubMed ID: 33863777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small-molecule RA-9 inhibits proteasome-associated DUBs and ovarian cancer in vitro and in vivo via exacerbating unfolded protein responses.
    Coughlin K; Anchoori R; Iizuka Y; Meints J; MacNeill L; Vogel RI; Orlowski RZ; Lee MK; Roden RB; Bazzaro M
    Clin Cancer Res; 2014 Jun; 20(12):3174-86. PubMed ID: 24727327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the Ubiquitin-Proteasome System Using the UBA1 Inhibitor TAK-243 is a Potential Therapeutic Strategy for Small-Cell Lung Cancer.
    Majeed S; Aparnathi MK; Nixon KCJ; Venkatasubramanian V; Rahman F; Song L; Weiss J; Barayan R; Sugumar V; Barghout SH; Pearson JD; Bremner R; Schimmer AD; Tsao MS; Liu G; Lok BH
    Clin Cancer Res; 2022 May; 28(9):1966-1978. PubMed ID: 35165102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Deubiquitinating Enzymes and Autophagy in Cancer.
    Mooneyham A; Bazzaro M
    Methods Mol Biol; 2017; 1513():49-59. PubMed ID: 27807830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Small Molecules Targeting Ubiquitin-Proteasome System for Cancer Therapy.
    Ao N; Chen Q; Liu G
    Comb Chem High Throughput Screen; 2017; 20(5):403-413. PubMed ID: 28699494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and mechanistic studies of a novel ubiquitin E1 inhibitor.
    Ungermannova D; Parker SJ; Nasveschuk CG; Chapnick DA; Phillips AJ; Kuchta RD; Liu X
    J Biomol Screen; 2012 Apr; 17(4):421-34. PubMed ID: 22274912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential Inhibition of Human and Trypanosome Ubiquitin E1S by TAK-243 Offers Possibilities for Parasite Selective Inhibitors.
    Boer DR; Bijlmakers MJ
    Sci Rep; 2019 Nov; 9(1):16195. PubMed ID: 31700050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting a helix-in-groove interaction between E1 and E2 blocks ubiquitin transfer.
    Cathcart AM; Bird GH; Wales TE; Herce HD; Harvey EP; Hauseman ZJ; Newman CE; Adhikary U; Prew MS; Oo T; Lee S; Engen JR; Walensky LD
    Nat Chem Biol; 2020 Nov; 16(11):1218-1226. PubMed ID: 32807965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allosteric Inhibition of Ubiquitin-like Modifications by a Class of Inhibitor of SUMO-Activating Enzyme.
    Li YJ; Du L; Wang J; Vega R; Lee TD; Miao Y; Aldana-Masangkay G; Samuels ER; Li B; Ouyang SX; Colayco SA; Bobkova EV; Divlianska DB; Sergienko E; Chung TDY; Fakih M; Chen Y
    Cell Chem Biol; 2019 Feb; 26(2):278-288.e6. PubMed ID: 30581133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ubiquitin-activating enzyme UBA1 is required for cellular response to DNA damage.
    Moudry P; Lukas C; Macurek L; Hanzlikova H; Hodny Z; Lukas J; Bartek J
    Cell Cycle; 2012 Apr; 11(8):1573-82. PubMed ID: 22456334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sculpting the proteome with small molecules.
    King RW; Finley D
    Nat Chem Biol; 2014 Nov; 10(11):870-4. PubMed ID: 25325686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.